Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2009-11-17
pubmed:abstractText
Galectin-3 plays a role in atherosclerotic diseases, and the effect of adiponectin that protects from atherosclerotic diseases on monocytic galectin-3 was analysed. Adiponectin reduced galectin-3 mRNA, its cellular and soluble form, and this effect was impaired in T2D cells. Cellular galectin-3 was higher in monocytes of overweight than normal-weight donors and was highest in T2D cells. Cellular galectin-3 positively correlated with the BMI of the donors and negatively with soluble monocyte galectin-3. Circulating levels of total adiponectin did not correlate with cellular or soluble galectin-3 indicating that additional factors contribute to higher cellular monocytic galectin-3 in obesity and T2D.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/(6-(4-(2-piperidin-1-ylethoxy)phenyl..., http://linkedlifedata.com/resource/pubmed/chemical/AICA ribonucleotide, http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin, http://linkedlifedata.com/resource/pubmed/chemical/Aminoimidazole Carboxamide, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Galectin 3, http://linkedlifedata.com/resource/pubmed/chemical/Metformin, http://linkedlifedata.com/resource/pubmed/chemical/Oleic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Palmitic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleotides
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1873-3468
pubmed:author
pubmed:issnType
Electronic
pubmed:day
19
pubmed:volume
583
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3718-24
pubmed:meshHeading
pubmed-meshheading:19818774-Adiponectin, pubmed-meshheading:19818774-Adult, pubmed-meshheading:19818774-Aged, pubmed-meshheading:19818774-Aged, 80 and over, pubmed-meshheading:19818774-Aminoimidazole Carboxamide, pubmed-meshheading:19818774-Body Mass Index, pubmed-meshheading:19818774-Cells, Cultured, pubmed-meshheading:19818774-Cholesterol, pubmed-meshheading:19818774-Diabetes Mellitus, Type 2, pubmed-meshheading:19818774-Dose-Response Relationship, Drug, pubmed-meshheading:19818774-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:19818774-Galectin 3, pubmed-meshheading:19818774-Humans, pubmed-meshheading:19818774-Immunoblotting, pubmed-meshheading:19818774-Male, pubmed-meshheading:19818774-Metformin, pubmed-meshheading:19818774-Middle Aged, pubmed-meshheading:19818774-Monocytes, pubmed-meshheading:19818774-Oleic Acid, pubmed-meshheading:19818774-Palmitic Acid, pubmed-meshheading:19818774-Pyrazoles, pubmed-meshheading:19818774-Pyrimidines, pubmed-meshheading:19818774-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19818774-Ribonucleotides, pubmed-meshheading:19818774-Solubility, pubmed-meshheading:19818774-Time Factors
pubmed:year
2009
pubmed:articleTitle
Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes.
pubmed:affiliation
Department of Internal Medicine I, Regensburg University Hospital, D-93042 Regensburg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't